Dermal lymphatic dilation in a mouse model of alopecia areata

Experimental and Molecular Pathology

Volumn 100, Issue 2, 2016, Pages 332-336

  Sundberg, John P ^a,b   Pratt, C Herbert ^a   Silva, Kathleen A ^a   Kennedy, Victoria E ^a   Stearns, Timothy M ^a,d   Sundberg, Beth A ^a   King, Lloyd E ^b   HogenEsch, Harm ^c  

^a JACKSON LABORATORY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

^d MOUNT DESERT ISLAND BIOLOGICAL LABORATORY   (United States)

Author keywords

Autoimmune disease; Inflammation; Lymphatics; LYVE1; PECAM1; SMA

Indexed keywords

CELL MARKER; LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; UNCLASSIFIED DRUG; GLYCOPROTEIN; XLKD1 PROTEIN, MOUSE;

ALOPECIA AREATA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE; GENETIC TRANSCRIPTION; HAIR FOLLICLE; LYMPH VESSEL; LYVE1 GENE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; SKIN GRAFT; UPREGULATION; ANIMAL; C3H MOUSE; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOHISTOCHEMISTRY; LYMPHATIC SYSTEM; METABOLISM; PATHOLOGY; PROCEDURES; SKIN; SKIN TRANSPLANTATION; TIME FACTOR; VASCULARIZATION;

ALOPECIA AREATA; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HAIR FOLLICLE; IMMUNOHISTOCHEMISTRY; LYMPHATIC SYSTEM; LYMPHATIC VESSELS; MICE, INBRED C3H; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SKIN; SKIN TRANSPLANTATION; TIME FACTORS;

EID: 84960395158     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2016.03.001     Document Type: Article

References (45)

1. Alitalo K., et al. Lymphangiogenesis in development and human disease. Nature 2005, 438:946-953.
2. Binder R.L., et al. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen. Cancer Res. 1998, 58:4314-4323.
3. Carroll J., et al. Gene array profiling and immunomodulation studies define a cell mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J. Investig. Dermatol. 2002, 119:392-402.
4. Dellinger M.T., et al. Vascular endothelial growth factor receptor-2 promotes the development of the lymphatic vasculature. PLoS ONE 2013, 8:e74686.
5. Duncan F.J., et al. Endogenous retinoids in the pathogenesis of alopecia areata. J. Investig. Dermatol. 2013, 133:334-343.
6. Fong G.H., et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376:66-70.
7. Helms C., et al. The tetratricopeptide repeat domain 7 gene is mutated in flaky skin mice: a model for psoriasis, autoimmunity, and anemia. Exp. Biol. Med. 2005, 230:659-667.
8. Ho V.C., et al. Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient mice. Circulation 2012, 126:741-752.
9. HogenEsch H., et al. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am. J. Pathol. 1993, 143:972-982.
10. Ikeda F., et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 2011, 471:637-641.
11. Iwami D., et al. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics. Transplantation 2015, 99:668-677.
12. Jackson D.G. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 2004, 112:526-538.
13. Johnson L.A., Jackson D.G. The cytokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics. J. Cell Sci. 2013, 126:5259-5270.
14. Karaman S., et al. Decline of lymphatic vessel density and function in murine skin during aging. Angiogenesis 2015, 18:489-498.
15. Karlsen T.V., et al. Transcapillary fluid balance consequences of missing initial lymphatics studied in a mouse model of primary lymphoedema. J. Physiol. 2006, 574:583-596.
16. Kisanuki Y.Y., et al. Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension 2010, 56:121-128.
17. Konger R.L., et al. Spatiotemporal assessments of dermal hyperemia enable accurate prediction of experimental cutaneous carcinogenesis as well as chemopreventive activity. Cancer Res. 2013, 73:150-159.
18. Kurihara Y., et al. Elevated blood pressure and craniofaclal abnormalities in mice deficient in endothelin-1. Nature 1994, 368:703-710.
19. Kuwaki T., et al. Endothelin in the central control of cardiovascular and respiratory functions. Clin. Exp. Pharmacol. Physiol. 1999, 26:989-994.
20. Liang Y., et al. Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice. J. Investig. Dermatol. 2011, 131:141-149.
21. McElwee K.J., et al. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J. Investig. Dermatol. 1998, 111:797-803.
22. McElwee K., et al. Spontaneous alopecia areata-like hair loss in one congenic and seven inbred laboratory mouse strains. J. Investig. Dermatol. Symp. Proc. 1999, 4:202-206.
23. McPhee C.G., et al. Gene expression studies identify Cxcr3 and its ligands, Cxcl9, Cxcl10, and Cxcl11 in the pathogenesis of alopecia areata in the mouse. J. Investig. Dermatol. 2012, 132:1736-1738.
24. Mijailović B., et al. Contact thermometry of lesions in alopecia areata. Vojnosanit. Pregl. 1997, 54:31-33.
25. Nagy J.A., et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J. Exp. Med. 2002, 196:1497-1506.
26. Ohl L., et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004, 21:279-288.
27. Omatsu Y., et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010, 33:387-399.
28. Patan S. Vasculogenesis and angiogenesis. Cancer Treat. Res. 2004, 117:3-32.
29. Peters A., et al. Podoplanin negatively regulates CD4+ effector T cell responses. J. Clin. Invest. 2015, 125:129-140.
30. Pullinger B.D., FLorey H.W. Proliferation of lymphatics in inflammation. J. Pathol. Bacteriol. 1937, 45:157-170.
31. Rueda P., et al. Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions. Circulation 2012, 126:1882-1895.
32. Schacht V., et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO 2003, 22:3546-3556.
33. Seo B., et al. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994, 89:1203-1208.
34. Seymour R.E., et al. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun. 2007, 8:416-421.
35. Silva K.A., Sundberg J.P. Necropsy methods. The Laboratory Mouse 2012, 779-806. Academic Press, London. H.J. Hedrich (Ed.).
36. Silva K.A., Sundberg J.P. Surgical methods for full thickness skin grafts to induce alopecia areata in C3H/HeJ mice. Comp. Med. 2013, 63:392-397.
37. Skoutelis A., et al. Angiogenic activity is defective in monocytes from patients with alopecia universalis. J. Investig. Dermatol. 1990, 95:139-143.
38. Sundberg J.P., et al. Alopecia areata in aging C3H/HeJ mice. J. Investig. Dermatol. 1994, 102:847-856.
39. Sundberg J.P., et al. Development and progression of psoriasiform dermatitis and systemic lesions in the flaky skin (fsn) mouse mutant. Pathobiology 1997, 65:271-286.
40. Sundberg J.P., et al. Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J. Investig. Dermatol. 2003, 120:771-775.
41. Sundberg J.P., et al. Spontaneous and experimental skin-graft-transfer mouse models of alopecia areata. Animal Models of Human Inflammatory Skin Diseases 2004, 429-449. CRC Press, Boca Raton. L.S. Chan (Ed.).
42. Uchida Y., et al. Class 3 semaphorins negatively regulate dermal lymphatic network formation. Biol. Open 2015, 4:1194-1205.
43. Wang Z., et al. SHARPIN is a key regulator of immune and inflammatory responses. J. Cell. Mol. Med. 2012, 16:2271-2279.
44. Wang Z., et al. SHARPIN is essential for cytokine production, NF-κB signaling, and induction of Th1 differentiation by dendritic cells. PLoS ONE 2012, 7:e31809.
45. Yanagisawa H., et al. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J. Clin. Invest. 2000, 105:1373-1382.